The relevance of biomaterials to the prevention and treatment of osteoporosis

Osteoporosis is a worldwide disease with a very high prevalence in humans older than 50. The main clinical consequences are bone fractures, which often lead to patient disability or even death. A number of commercial biomaterials are currently used to treat osteoporotic bone fractures, but most of t...

Descripción completa

Detalles Bibliográficos
Autores: Arcos Navarrete, Daniel, Boccaccini, A. R., Bohner, M., Díez Pérez, A., Epple, M., Gómez Barrena, E., Herrera, A., Planell, J. A., Rodríguez Manas, L., Vallet Regí, María Dulce Nombre
Tipo de recurso: artículo
Fecha de publicación:2014
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/35363
Acceso en línea:https://hdl.handle.net/20.500.14352/35363
Access Level:acceso abierto
Palabra clave:546
615.46
Osteoporosis
Biomaterials
Ageing
Bone
Materiales
Química inorgánica (Química)
3312 Tecnología de Materiales
2303 Química Inorgánica
id ES_20a0804d08fb562b95b17fed625c96ff
oai_identifier_str oai:docta.ucm.es:20.500.14352/35363
network_acronym_str ES
network_name_str España
repository_id_str
spelling The relevance of biomaterials to the prevention and treatment of osteoporosisArcos Navarrete, DanielBoccaccini, A. R.Bohner, M.Díez Pérez, A.Epple, M.Gómez Barrena, E.Herrera, A.Planell, J. A.Rodríguez Manas, L.Vallet Regí, María Dulce Nombre546615.46OsteoporosisBiomaterialsAgeingBoneMaterialesQuímica inorgánica (Química)3312 Tecnología de Materiales2303 Química InorgánicaOsteoporosis is a worldwide disease with a very high prevalence in humans older than 50. The main clinical consequences are bone fractures, which often lead to patient disability or even death. A number of commercial biomaterials are currently used to treat osteoporotic bone fractures, but most of these have not been specifically designed for that purpose. Many drug- or cell-loaded biomaterials have been proposed in research laboratories, but very few have received approval for commercial use. In order to analyze this scenario and propose alternatives to overcome it, the Spanish and European Network of Excellence for the Prevention and Treatment of Osteoporotic Fractures, ‘‘Ageing’’, was created. This network integrates three communities, e.g. clinicians, materials scientists and industrial advisors, tackling the same problem from three different points of view. Keeping in mind the premise ‘‘living longer, living better’’, this commentary is the result of the thoughts, proposals and conclusions obtained after one year working in the framework of this network.ElsevierUniversidad Complutense de Madrid20142014-01-0120142014-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/35363reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/353632026-06-02T12:44:21Z
dc.title.none.fl_str_mv The relevance of biomaterials to the prevention and treatment of osteoporosis
title The relevance of biomaterials to the prevention and treatment of osteoporosis
spellingShingle The relevance of biomaterials to the prevention and treatment of osteoporosis
Arcos Navarrete, Daniel
546
615.46
Osteoporosis
Biomaterials
Ageing
Bone
Materiales
Química inorgánica (Química)
3312 Tecnología de Materiales
2303 Química Inorgánica
title_short The relevance of biomaterials to the prevention and treatment of osteoporosis
title_full The relevance of biomaterials to the prevention and treatment of osteoporosis
title_fullStr The relevance of biomaterials to the prevention and treatment of osteoporosis
title_full_unstemmed The relevance of biomaterials to the prevention and treatment of osteoporosis
title_sort The relevance of biomaterials to the prevention and treatment of osteoporosis
dc.creator.none.fl_str_mv Arcos Navarrete, Daniel
Boccaccini, A. R.
Bohner, M.
Díez Pérez, A.
Epple, M.
Gómez Barrena, E.
Herrera, A.
Planell, J. A.
Rodríguez Manas, L.
Vallet Regí, María Dulce Nombre
author Arcos Navarrete, Daniel
author_facet Arcos Navarrete, Daniel
Boccaccini, A. R.
Bohner, M.
Díez Pérez, A.
Epple, M.
Gómez Barrena, E.
Herrera, A.
Planell, J. A.
Rodríguez Manas, L.
Vallet Regí, María Dulce Nombre
author_role author
author2 Boccaccini, A. R.
Bohner, M.
Díez Pérez, A.
Epple, M.
Gómez Barrena, E.
Herrera, A.
Planell, J. A.
Rodríguez Manas, L.
Vallet Regí, María Dulce Nombre
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidad Complutense de Madrid
dc.subject.none.fl_str_mv 546
615.46
Osteoporosis
Biomaterials
Ageing
Bone
Materiales
Química inorgánica (Química)
3312 Tecnología de Materiales
2303 Química Inorgánica
topic 546
615.46
Osteoporosis
Biomaterials
Ageing
Bone
Materiales
Química inorgánica (Química)
3312 Tecnología de Materiales
2303 Química Inorgánica
description Osteoporosis is a worldwide disease with a very high prevalence in humans older than 50. The main clinical consequences are bone fractures, which often lead to patient disability or even death. A number of commercial biomaterials are currently used to treat osteoporotic bone fractures, but most of these have not been specifically designed for that purpose. Many drug- or cell-loaded biomaterials have been proposed in research laboratories, but very few have received approval for commercial use. In order to analyze this scenario and propose alternatives to overcome it, the Spanish and European Network of Excellence for the Prevention and Treatment of Osteoporotic Fractures, ‘‘Ageing’’, was created. This network integrates three communities, e.g. clinicians, materials scientists and industrial advisors, tackling the same problem from three different points of view. Keeping in mind the premise ‘‘living longer, living better’’, this commentary is the result of the thoughts, proposals and conclusions obtained after one year working in the framework of this network.
publishDate 2014
dc.date.none.fl_str_mv 2014
2014-01-01
2014
2014-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.14352/35363
url https://hdl.handle.net/20.500.14352/35363
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Docta Complutense
instname:Universidad Complutense de Madrid (UCM)
instname_str Universidad Complutense de Madrid (UCM)
reponame_str Docta Complutense
collection Docta Complutense
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404469631909888
score 15.300719

Similares en LA Referencia